Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
- PMID: 17200671
- DOI: 10.1038/ng1947
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Abstract
PALB2 was recently identified as a nuclear binding partner of BRCA2. Biallelic BRCA2 mutations cause Fanconi anemia subtype FA-D1 and predispose to childhood malignancies. We identified pathogenic mutations in PALB2 (also known as FANCN) in seven families affected with Fanconi anemia and cancer in early childhood, demonstrating that biallelic PALB2 mutations cause a new subtype of Fanconi anemia, FA-N, and, similar to biallelic BRCA2 mutations, confer a high risk of childhood cancer.
Comment in
-
Fanconi anemia and breast cancer susceptibility.Nat Genet. 2007 Feb;39(2):142-3. doi: 10.1038/ng0207-142. Nat Genet. 2007. PMID: 17262024 No abstract available.
Similar articles
-
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.Nat Genet. 2007 Feb;39(2):159-61. doi: 10.1038/ng1942. Epub 2006 Dec 31. Nat Genet. 2007. PMID: 17200672
-
PALB2/FANCN: recombining cancer and Fanconi anemia.Cancer Res. 2010 Oct 1;70(19):7353-9. doi: 10.1158/0008-5472.CAN-10-1012. Epub 2010 Sep 21. Cancer Res. 2010. PMID: 20858716 Free PMC article. Review.
-
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.Nat Genet. 2007 Feb;39(2):165-7. doi: 10.1038/ng1959. Epub 2006 Dec 31. Nat Genet. 2007. PMID: 17200668 Free PMC article.
-
Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.Breast Cancer Res Treat. 2009 Feb;113(3):545-51. doi: 10.1007/s10549-008-9945-0. Epub 2008 Feb 27. Breast Cancer Res Treat. 2009. PMID: 18302019
-
Exploring the roles of PALB2 at the crossroads of DNA repair and cancer.Biochem J. 2014 Jun 15;460(3):331-42. doi: 10.1042/BJ20140208. Biochem J. 2014. PMID: 24870022 Review.
Cited by
-
Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American population.BMC Cancer. 2015 Jan 31;15:30. doi: 10.1186/s12885-015-1033-3. BMC Cancer. 2015. PMID: 25636233 Free PMC article.
-
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family.Breast Cancer Res Treat. 2016 Dec;160(3):447-456. doi: 10.1007/s10549-016-4021-7. Epub 2016 Oct 18. Breast Cancer Res Treat. 2016. PMID: 27757719 Free PMC article.
-
Inhibition of homologous recombination by the PCNA-interacting protein PARI.Mol Cell. 2012 Jan 13;45(1):75-86. doi: 10.1016/j.molcel.2011.11.010. Epub 2011 Dec 6. Mol Cell. 2012. PMID: 22153967 Free PMC article.
-
TNF-α signaling in Fanconi anemia.Blood Cells Mol Dis. 2014 Jan;52(1):2-11. doi: 10.1016/j.bcmd.2013.06.005. Epub 2013 Jul 24. Blood Cells Mol Dis. 2014. PMID: 23890415 Free PMC article. Review.
-
Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses.NPJ Breast Cancer. 2021 Apr 23;7(1):46. doi: 10.1038/s41523-021-00254-4. NPJ Breast Cancer. 2021. PMID: 33893315 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous